Home > Financial Ratios > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results

MOREPEN LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 9.385.618.849.988.03

What is the latest Core EBITDA Margin ratio of MOREPEN LABORATORIES ?

The latest Core EBITDA Margin ratio of MOREPEN LABORATORIES is 9.38 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar20249.38
Mar20235.61
Mar20228.84
Mar20219.98
Mar20208.03

How is Core EBITDA Margin of MOREPEN LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2024 9.38
67.20
Mar2023 5.61
-36.54
Mar2022 8.84
-11.42
Mar2021 9.98
24.28
Mar2020 8.03 -

Other Financial Ratios of MOREPEN LABORATORIES


Compare Core EBITDA Margin ratio of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹3,428.8 Cr -0.3% 4% 9.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

-0.3%

4%

9.3%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses